Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

Clinical trial NCT02210078 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02210078
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cytomegaloviral Infection Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

Start date: 2015-02-19
Primary completion: 2027-08-31
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.